Molnupiravir
Molnupiravir[edit | edit source]
Molnupiravir is an antiviral medication that is used to treat COVID-19. It was developed by the pharmaceutical companies Merck & Co. and Ridgeback Biotherapeutics. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action by introducing errors into the viral RNA during replication.
Mechanism of Action[edit | edit source]
Molnupiravir works by incorporating itself into the viral RNA. Once inside the viral RNA, it causes mutations during the replication process. These mutations accumulate and lead to "error catastrophe," which reduces the ability of the virus to replicate and spread.
The drug is metabolized into its active form, N4-hydroxycytidine, which is then phosphorylated to the active triphosphate form. This active form is incorporated into the viral RNA by the viral RNA-dependent RNA polymerase.
Chemical Properties[edit | edit source]
Molnupiravir is a prodrug, meaning it is metabolized in the body to become an active pharmacological agent. Its chemical structure allows it to mimic the natural nucleosides used by the virus to replicate its RNA.
Synthesis[edit | edit source]
The synthesis of molnupiravir involves several chemical reactions starting from uridine, a naturally occurring nucleoside. The process includes the introduction of a hydroxylamine group to form N4-hydroxycytidine, which is then converted into molnupiravir.
Bonding and Interaction with Viral RNA[edit | edit source]
Molnupiravir can pair with both guanine and adenine, leading to G-to-A and C-to-U transitions in the viral genome. This dual pairing ability is crucial for its mechanism of inducing lethal mutagenesis in the virus.
Clinical Use[edit | edit source]
Molnupiravir is administered orally and is used in the treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe disease. It is typically prescribed for patients who cannot receive other treatments or for whom other treatments are not appropriate.
Safety and Efficacy[edit | edit source]
Clinical trials have shown that molnupiravir can reduce the risk of hospitalization and death in patients with COVID-19. However, its use is subject to ongoing evaluation, and it is important to consider potential side effects and contraindications.
Related Pages[edit | edit source]
Drugs for HIV Infection, in the Subclass Antiretroviral Agents
- Fusion Inhibitors (HIV)
- Integrase Inhibitors (HIV)
- Nonnucleoside Reverse Transcriptase Inhibitors (HIV)
- Nucleoside Analogues (HIV)
- Protease Inhibitors (HIV)
HCV NS5A Inhibitors
HCV NS5B Inhibitors (Polymerase inhibitors)
- Asunaprevir, Boceprevir, Glecaprevir, Grazoprevir, Paritaprevir, Simeprevir, Telaprevir, Voxilaprevir
Combination Therapies
Drugs for Herpes Virus
- infections (HSV), CMV, others
Acyclovir, Cidofovir, Famciclovir, Foscarnet, Ganciclovir, Valacyclovir, Valganciclovir
Drugs for Influenza
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD